In Phase A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra individuals will be enrolled on the identified monotherapy dosign regimen. In Section B, members will get oral ruxolitinib and ABBV-744 will be provided as "insert-on" therapy. In Phase C, contributors https://messiahnzkvc.glifeblog.com/31222291/a-simple-key-for-abbv-744-brd4-inhibition-in-cancer-cell-lines-unveiled